A citation-based method for searching scientific literature

Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij, Alfredo Carrato, Josep Lloreta, José A Lorente, Enrique Carrillo-de Santa Pau, Roy G Masius, Manolis Kogevinas, Ewout W Steyerberg, Angela A G van Tilborg, Cheno Abas, Torben F Orntoft, Tahlita C M Zuiverloon, Núria Malats, Ellen C Zwarthoff, Francisco X Real. Eur Urol 2014
Times Cited: 156



Bas W G van Rhijn, André N Vis, Theo H van der Kwast, Wim J Kirkels, François Radvanyi, Engelbert C M Ooms, Dominique K Chopin, Egbert R Boevé, Adriaan C Jöbsis, Ellen C Zwarthoff. J Clin Oncol 2003
Times Cited: 227




List of shared articles



Times cited

Advances in bladder cancer biology and therapy.
Linda Tran, Jin-Fen Xiao, Neeraj Agarwal, Jason E Duex, Dan Theodorescu. Nat Rev Cancer 2021
6

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.
Gottfrid Sjödahl, Pontus Eriksson, Oliver Patschan, Nour-Al-Dain Marzouka, Lovisa Jakobsson, Carina Bernardo, Kristina Lövgren, Gunilla Chebil, Ellen Zwarthoff, Fredrik Liedberg,[...]. Int J Cancer 2020
13

Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients.
Caroline A Sieverink, Rui P M Batista, Hugo J M Prazeres, João Vinagre, Cristina Sampaio, Ricardo R Leão, Valdemar Máximo, J Alfred Witjes, Paula Soares. Diagnostics (Basel) 2020
3

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.
Rui Batista, João Vinagre, Hugo Prazeres, Cristina Sampaio, Pedro Peralta, Paulo Conceição, Amílcar Sismeiro, Ricardo Leão, Andreia Gomes, Frederico Furriel,[...]. Front Genet 2019
13

Analysis of Point Mutations in Clinical Samples of Urothelial Carcinoma.
Mustafa Alamyar, Ellen C Zwarthoff. Methods Mol Biol 2018
0

Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
Chung-Chieh Wang, Chao-Yuan Huang, Yu-Lin Jhuang, Chih-Chi Chen, Yung-Ming Jeng. Histopathology 2018
8

Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.
Kim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, Ferran Algaba, Naeromy Y C Welvaart, Willemien Beukers, Ulrika Segersten, Bastian Keck, Tobias Maurer, Tatjana Simic,[...]. Clin Cancer Res 2018
37

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
Kim E M van Kessel, Willemien Beukers, Irene Lurkin, Angelique Ziel-van der Made, Kirstin A van der Keur, Joost L Boormans, Lars Dyrskjøt, Mirari Márquez, Torben F Ørntoft, Francisco X Real,[...]. J Urol 2017
60

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
Emil Christensen, Karin Birkenkamp-Demtröder, Iver Nordentoft, Søren Høyer, Kirstin van der Keur, Kim van Kessel, Ellen Zwarthoff, Mads Agerbæk, Torben Falck Ørntoft, Jørgen Bjerggaard Jensen,[...]. Eur Urol 2017
90

Emerging Bladder Cancer Biomarkers and Targets of Therapy.
George J Netto, Laura J Tafe. Urol Clin North Am 2016
14